KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Receivables - Other (2018 - 2024)

Historic Receivables - Other for Amgen (AMGN) over the last 8 years, with Q4 2024 value amounting to $521.0 million.

  • Amgen's Receivables - Other rose 378.49% to $521.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $521.0 million, marking a year-over-year increase of 378.49%. This contributed to the annual value of $521.0 million for FY2024, which is 378.49% up from last year.
  • According to the latest figures from Q4 2024, Amgen's Receivables - Other is $521.0 million, which was up 378.49% from $502.0 million recorded in Q4 2023.
  • Over the past 5 years, Amgen's Receivables - Other peaked at $780.0 million during Q4 2021, and registered a low of $502.0 million during Q4 2023.
  • For the 5-year period, Amgen's Receivables - Other averaged around $617.2 million, with its median value being $583.0 million (2020).
  • Per our database at Business Quant, Amgen's Receivables - Other surged by 3379.07% in 2021 and then plummeted by 2828.57% in 2023.
  • Over the past 5 years, Amgen's Receivables - Other (Quarter) stood at $583.0 million in 2020, then soared by 33.79% to $780.0 million in 2021, then decreased by 10.26% to $700.0 million in 2022, then dropped by 28.29% to $502.0 million in 2023, then increased by 3.78% to $521.0 million in 2024.
  • Its Receivables - Other was $521.0 million in Q4 2024, compared to $502.0 million in Q4 2023 and $700.0 million in Q4 2022.